section name header

Information

  1. Brunton LL, Lazo JS, Parker KL, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics. 11th ed. New York, NY: The McGraw Hill Companies, Inc; 2006:71-93.
  2. Brauch H, Jordan VC. Targeting of tamoxifen to enhance antitumor action for the treatment and prevention of breast cancer: the ‘personalized' approach. Eur J Cancer. 2009;45:2274-2283.
  3. Goetz MP, Knox SK, Suman VJ, et al. The impact of cytochrome p450 2d6 metabolism in women receiving adjuvant tamoxifen. Breast Cancer Res Treat. 2007;101:113-121. doi: 10.1007/s10549-006-9428-9430.
  4. Gasche Y, Daali Y, Fathi M, et al. Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med. 2004;351(27):2827-2831.
  5. Wilkes GM. Drug essentials: The cytochrome P450 microenzyme system and targeted therapies. Nurse Edition. 2009;23(2):22-28.
  6. Winklejohn DL. Oral chemotherapy medications: the need for a nurse's touch. Clin J Oncol Nurs. 2007;11(6):793-796.
  7. Hartigan K. Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs. 2003;7(6)(suppl 6):S21-24.
  8. Hollywood E, Semple D. Nursing strategies for patients on oral chemotherapy. Oncology. 2001;15(1)(suppl 2):37-39.
  9. Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009;59:56-66.
  10. Partridge A, Kato PM, DeMichele A. Adherence to oral cancer therapies: challenges and opportunities. In: American Society of Clinical Oncology Educational Book, 2009. McLean, VA: American Society of Clinical Oncology; 2009.
  11. De Geest S, Schafer-Keller P, Denhaerynck K, et al. Supporting medication adherence in renal transplantation (SMART): A pilot RCT to improve adherence to immunosuppressive regimens. Clin Transplant. 2006;20(3):359-368.
  12. Weingart SN, Brown E, Bach PB, et al. NCCN task force report: oral chemotherapy. J Natl Compr Cancer Network. 2008;6(suppl 3):S1-S14.
  13. Veronesi A, Pizzichetta MA, Ferlante MA, et al. Tamoxifen as adjuvant after surgery for breast cancer and tamoxifen or placebo as chemoprevention in healthy women: different compliance with treatment. Tumori. 1998;84:372-375.
  14. Lash TL, Fox MP, Westrup JL, Fink AK, Silliman RA. Adherence to tamoxifen over the 5-year course. Breast Cancer Res Treat. 2006;99:215-220.
  15. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94(9):652-661.
  16. Aisner J. Overview of the changing paradigm in cancer treatment. Oral chemotherarpy. Am J Health Syst Pharm. 2007;64(9)(suppl 5):S4-S7.
  17. Avery K. Medication non-adherence issues with refugee and immigrant patients. Ethnomed Web site. http://www.ethnomed.org/clin_topics/pharmacy/non_adherence.htm. Published August 2007. Accessed October 3, 2009.
  18. Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family focused education. Cancer Nurs. 2007;30(2):112-122.
  19. Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH. The Health Belief Model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18:2348-366.
  20. American Cancer Society. Cancer Facts and Figures 2007. Atlanta, GA: American Cancer Society; 2007:35.
  21. American Cancer Society. Cancer Facts and Figures 2009. Atlanta, GA: American Cancer Society; 2009:12.
  22. Bartel S. Safe practices and financial considerations in using oral chemotherapeutic agents. Am J Health Syst Pharm. 2007;64(9)(suppl 51):S8-S14.
  23. Chan A, Leow CY, Hian SM. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center. J Oncol Pharm Pract. 2009;15(3):161-165. Abstract.
  24. Partridge AH. Helping breast cancer patients adhere to oral adjuvant hormonal therapy regimens. Comm Oncol. 2007;4:725-731.
  25. Projects in Knowledge. Caring for Oncology Patients: Tips and Tools for Managing Targeted Therapy. Little Falls, NJ: Projects in Knowledge Inc; 2009. In press.
  26. Jacobsen JO, Polovich M, McNiff KK et al. American Society of Clinical Oncology. ASCO/ONS chemotherapy administration safety standards. J Clin Oncol. 2009; published ahead of print on October 14, 2009, as 10.1200/JCO.2009.25.1264, available at http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2009.25.1264. Accessed October 22, 2009.
  27. Barefoot BE et al. Intramuscular immunization with a vesicular stomatitis virus recombinant expressing the influenza hemagglutinin provides post-exposure protection against lethal influenza challenge. Vaccine. 2009.